CLDX EPS Estimates
Celldex Therapeutics, Inc.
$28.56
-$0.38(-1.30%)
32
Overall
60
Value
9
Tech
28
Quality
Market Cap
$2.27B
Volume
19.79K
52W Range
$22.10 - $45.14
Target Price
$63.29
CLDX EPS estimates: the consensus estimate for Celldex Therapeutics, Inc.'s current fiscal year is -$4.17 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CLDX EPS Estimates
- EPS estimate, current quarter
- $-1.02
- EPS estimate, next quarter
- $-1.04
- EPS estimate, current year
- $-4.17
- EPS estimate, next year
- $-4.26
- EPS growth, 3-year
- -17.57%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.90 |
| 2024 | $-2.45 |
| 2023 | $-2.92 |
| 2022 | $-2.40 |
| 2021 | $-1.64 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLDX | $28.56 | -1.3% | 19.79K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Celldex Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW